Published in ISRN Gastroenterol on November 07, 2013
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet (2002) 14.14
Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med (2010) 12.35
A simple index of Crohn's-disease activity. Lancet (1980) 11.12
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet (2008) 10.47
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med (2003) 8.49
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology (2006) 6.88
Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med (2004) 6.77
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis (2010) 6.75
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology (2006) 6.36
Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med (1999) 6.24
Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med (2007) 4.56
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. Ann Intern Med (2007) 4.39
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut (2007) 4.21
Certolizumab pegol for the treatment of Crohn's disease. N Engl J Med (2007) 4.07
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology (2008) 3.98
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis (2010) 3.97
Predictors of Crohn's disease. Gastroenterology (2006) 3.96
Management of Crohn's disease in adults. Am J Gastroenterol (2009) 3.94
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis (2009) 3.66
Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol (2000) 3.36
Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials. Clin Gastroenterol Hepatol (2004) 2.65
5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study. Am J Gastroenterol (2011) 2.41
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol (2008) 2.15
Systematic review: Endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther (2007) 2.15
Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol (2011) 2.04
Duodenal Crohn's disease: an analysis of 89 cases. Am J Gastroenterol (1989) 1.91
Review article: loss of response to anti-TNF treatments in Crohn's disease. Aliment Pharmacol Ther (2011) 1.86
Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2006) 1.79
Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol (2011) 1.60
Review article: medical, surgical and radiological management of perianal Crohn's fistulas. Aliment Pharmacol Ther (2010) 1.57
Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines. Am J Gastroenterol (2010) 1.47
Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease. Am J Gastroenterol (1997) 1.46
An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol (2011) 1.42
Healing of perineal Crohn's disease with metronidazole. Gastroenterology (1980) 1.37
Azathioprine for maintaining remission of Crohn's disease. Cochrane Database Syst Rev (2000) 1.32
Proximal Crohn's disease: review of the clinicopathologic features and therapy. Inflamm Bowel Dis (2001) 1.26
Diagnosis and management of fistulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol (2009) 1.25
Methotrexate: first-line or second-line immunomodulator? Eur J Gastroenterol Hepatol (2003) 1.17
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis (2009) 1.14
Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev (2008) 1.14
Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality? Eur J Clin Pharmacol (2009) 1.05
Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther (2003) 1.03
Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Dis Colon Rectum (2003) 1.03
Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease? Aliment Pharmacol Ther (2004) 1.03
A study at 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dis Sci (1996) 1.03
Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther (2004) 1.02
Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease. Br J Surg (2010) 1.01
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. Am J Gastroenterol (2000) 0.97
Methotrexate for induction of remission in refractory Crohn's disease. Cochrane Database Syst Rev (2005) 0.96
Course of Crohn's disease during pregnancy and its effect on pregnancy outcome: a retrospective review. Am J Perinatol (1995) 0.92
Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed? Hepatogastroenterology (2010) 0.84
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience. Gastroenterol Hepatol (2011) 0.81
Sexual transmission of HCV between spouses. Am J Gastroenterol (2005) 2.08
Terry's nail: an overlooked physical finding in cirrhosis. Hepatobiliary Pancreat Dis Int (2013) 1.99
Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas (2011) 1.71
The role of gastric Helicobacter pylori infection in laryngopharyngeal reflux disease. Otolaryngol Head Neck Surg (2006) 1.41
Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening. Scand J Gastroenterol (2014) 1.39
Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B. Antimicrob Agents Chemother (2013) 1.14
Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?). Hepatogastroenterology (2004) 1.03
Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J Hepatol (2003) 1.01
Protective effect of a potent antioxidant, pomegranate juice, in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Endourol (2008) 0.95
Pneumatic balloon dilatation in primary achalasia: the long-term follow-up results. Hepatogastroenterology (2005) 0.90
Association of gluten enteropathy and irritable bowel syndrome in adult Turkish population. Dig Dis Sci (2008) 0.88
Terlipressin and albumin combination treatment in hepatorenal syndrome. Hepatogastroenterology (2003) 0.87
Feasibility of endoscopic transesophageal thoracic sympathectomy (with video). Gastrointest Endosc (2009) 0.85
Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy. Acta Gastroenterol Belg (2007) 0.84
Crohn disease activity evaluated by Doppler ultrasonography of the superior mesenteric artery and the affected small-bowel segments. J Ultrasound Med (2005) 0.83
Alpha interferon and ribavirin combination therapy of chronic hepatitis D. Antimicrob Agents Chemother (2005) 0.83
Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis. Cancer Biother Radiopharm (2015) 0.82
Selective nuclear factor kappa-B inhibitors, pyrolidium dithiocarbamate and sulfasalazine, prevent the nephrotoxicity induced by gentamicin. BJU Int (2006) 0.82
Paraneoplastic porphyria cutanea tarda associated with cholangiocarcinoma: case report. Turk J Gastroenterol (2007) 0.80
Effects of lycopene on oxidative stress and remnant liver histology after partial hepatectomy in rats. Turk J Gastroenterol (2011) 0.79
Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low? Hepatogastroenterology (2009) 0.79
Could complement C4 be an alternative to biopsy for chronic hepatitis B histopathologic findings? J Clin Gastroenterol (2011) 0.79
Body weight reducing effect of oral boric acid intake. Int J Med Sci (2011) 0.78
Serum complement C4 in chronic hepatitis C: correlation with histopathologic findings and disease activity. Turk J Gastroenterol (2012) 0.77
Massive ascites as the initial manifestation of mantle cell lymphoma: a challenge for the gastroenterologist. Case Rep Gastroenterol (2012) 0.77
Rosai-Dorfman disease with diffuse gastrointestinal involvement. Eur J Gastroenterol Hepatol (2013) 0.77
Effects of Crataegus microphylla on vascular dysfunction in streptozotocin-induced diabetic rats. Phytother Res (2012) 0.77
Anti-pancreatic antibody in Turkish patients with inflammatory bowel disease and first-degree relatives. World J Gastroenterol (2010) 0.76
Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts: A retrospective cohort study. Medicine (Baltimore) (2017) 0.75
Methotrexate dose in current ECCO consensus on Crohn's disease. J Crohns Colitis (2010) 0.75
Comments on histologic predictors of fibrosis progression in posttransplant hepatitis C recurrence. Clin Gastroenterol Hepatol (2010) 0.75
Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B. Dig Dis Sci (2007) 0.75
Acute pancreatitis associated with H1N1 influenza during 2009 pandemic: a case report. Clin Res Hepatol Gastroenterol (2012) 0.75
[Culturability of rat bone marrow stromal cells and evaluation for osteoblastic formation]. Acta Orthop Traumatol Turc (2006) 0.75
Lamivudine treatment failure risks in chronic hepatitis B patients with low viral load. Digestion (2013) 0.75
Cyclosporin for severe ulcerative colitis attacks. Hepatogastroenterology (2003) 0.75
Efficacy of cyclosporin in severe ulcerative colitis attack. Turk J Gastroenterol (2002) 0.75
Distribution of gastric lymphoid follicles in Helicobacter pylori-associated gastritis. Hepatogastroenterology (2007) 0.75
Routinely evaluated clinical assays and laboratory tests [real test] and fibrosis stages of chronic hepatitis B and C. Turk J Gastroenterol (2014) 0.75
Ribavirin treatment in patients with chronic hepatitis C infection who had renal transplantation. Dig Surg (2005) 0.75
Angiographic embolization of large duodenal varix in a cirrhotic patient. Dig Liver Dis (2012) 0.75
A Cross-sectional Study to Assess the Prevalence of Pancreatic Exocrine Insufficiency Among Diabetes Mellitus Patients in Turkey. Pancreas (2016) 0.75
[Production and characterization of a glass-ceramic biomaterial and in vitro and in vivo evaluation of its biological effects]. Acta Orthop Traumatol Turc (2008) 0.75